Sens. Seek White House Backing For Pay-For-Delay Drug Bill
Law360 (November 9, 2018, 5:01 PM EST) -- Sens. Amy Klobuchar, D-Minn., and Chuck Grassley, R-Iowa, pointed to President Donald Trump’s criticism of high drug prices to ask for White House support for their latest version of a bill aimed at outlawing most so-called pay-for-delay deals between brand drugmakers and their would-be generic competitors.
The lawmakers on Thursday asked Trump to back their Preserve Access to Affordable Generics Act, introduced in past congressional sessions to no avail, that in its current form would treat most patent infringement settlements between brandmakers and generics companies as presumptively anticompetitive unless they speed generic entry, cover only the generics manufacturer’s “reasonable litigation expenses”...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!
Kirkland & Ellis LLP has redefined what it means to be the biggest of BigLaw — weighing in at 2,116 attorneys by year end 2018 and becoming the first firm since Law360 began tracking law firm head counts to top 2,000 U.S.-based attorneys.